Zynex(ZYXI) Prnewswire·2025-04-15 19:33Core Viewpoint - A securities class action lawsuit has been filed against Zynex, Inc. for alleged misconduct during the class period from March 13, 2023, to March 11, 2025, following reports of oversupplying medical devices and a significant revenue shortfall due to payment delays from insurers [1][4]. Company Overview - Zynex, Inc. is a medical device company based in Englewood, CO, specializing in electrotherapy devices for pain management and rehabilitation [2]. Legal Developments - A class action lawsuit has been initiated on behalf of investors who purchased Zynex securities during the specified class period, with a deadline of May 19, 2025, for potential lead plaintiff applications [1][2]. - The lawsuit follows a report by medical journal STAT, which accused Zynex of an "oversupplying scheme" that led to insurers removing the company from their networks [3]. Financial Performance - On March 11, 2025, Zynex reported a significant revenue shortfall for Q4 and the full year of 2024, attributing it to slower payments from certain payers, including a temporary suspension of payments from Tricare [4]. - Following the financial report, Zynex's stock price plummeted by 3.41 per share on March 12, 2025 [4].